Non-Current Assets
Deferred Tax Assets
Merck & Co. Deferred Tax Assets decreased by 127.0% to -$315M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 122.4%, from $1.41B to -$315M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows an upward trend with a 39.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 4, 2026
How to read this metric
An increase may indicate future tax savings, while a significant decrease might suggest a valuation allowance or utilization of benefits.
Detailed definition
Deferred tax assets represent future tax benefits arising from deductible temporary differences between the book value o...
Peer comparison
Common across large-cap pharmaceutical firms with significant R&D tax credits and global operations.
Metric ID:
deferred_tax_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.49B | $1.53B | $2.75B | $3.07B | $2.97B | $2.42B | $1.29B | $1.44B | $996M | $1.02B | $1.1B | $922M | $876M | $864M | $2.21B | $1.41B | $1.43B | $1.38B | $1.17B | -$315M |
| QoQ Change | — | +2.6% | +80.0% | +11.7% | -3.2% | -18.7% | -46.5% | +11.6% | -30.9% | +2.2% | +7.8% | -16.0% | -5.0% | -1.4% | +156.3% | -36.4% | +1.3% | -3.2% | -15.6% | -127.0% |
| YoY Change | — | — | — | — | +99.7% | +58.3% | -53.0% | -53.0% | -66.5% | -57.9% | -15.1% | -36.1% | -12.0% | -15.1% | +101.8% | +52.8% | +62.9% | +59.8% | -47.3% | -122.4% |
Range-$315M – $3.07B
CAGR-27.9%
Avg YoY Growth-2.7%
Median YoY Growth-15.1%
Current Streak3 quarters decline
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s deferred tax assets?
- Merck & Co. (MRK) reported deferred tax assets of -$315M in Q1 2026.
- How has Merck & Co.'s deferred tax assets changed year-over-year?
- Merck & Co.'s deferred tax assets decreased by 122.4% year-over-year, from $1.41B to -$315M.
- What is the long-term trend for Merck & Co.'s deferred tax assets?
- Over 5 years (2020 to 2025), Merck & Co.'s deferred tax assets has grown at a 39.2% compound annual growth rate (CAGR), from $223M to $1.17B.
- What does deferred tax assets mean?
- The value of future tax savings the company expects to realize due to accounting differences.